Christian Brühlmann
Corporate Officer/Principal bei ONCONETIX, INC.
Vermögen: 28 323 $ am 30.04.2024
Profil
Christian Brühlmann is the founder and the Chief Business Officer of Proteomedix AG, a company founded in 2010.
He is currently the Chief Strategy Officer at Onconetix, Inc., starting in 2023.
Mr. Brühlmann has a graduate degree from the University of Zurich.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCONETIX INC
1,06% | 05.04.2024 | 236 029 ( 1,06% ) | 28 323 $ | 30.04.2024 |
Aktive Positionen von Christian Brühlmann
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCONETIX, INC. | Corporate Officer/Principal | 01.12.2023 |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Gründer | 01.01.2010 |
Ausbildung von Christian Brühlmann
| University of Zurich | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
